B-MYB is required for recovery from the DNA damage-induced G2 checkpoint in p53 mutant cells
- PMID: 19383908
- DOI: 10.1158/0008-5472.CAN-08-4156
B-MYB is required for recovery from the DNA damage-induced G2 checkpoint in p53 mutant cells
Abstract
In response to DNA damage, several signaling pathways that arrest the cell cycle in G(1) and G(2) are activated. The down-regulation of mitotic genes contributes to the stable maintenance of the G(2) arrest. The human LINC or DREAM complex, together with the B-MYB transcription factor, plays an essential role in the expression of G(2)-M genes. Here, we show that DNA damage results in the p53-dependent binding of p130 and E2F4 to LINC and the dissociation of B-MYB from LINC. We find that B-MYB fails to dissociate from LINC in p53 mutant cells, that this contributes to increased G(2)-M gene expression in response to DNA damage in these cells, and, importantly, that B-MYB is required for recovery from the G(2) DNA damage checkpoint in p53-negative cells. Reanalysis of microarray expression data sets revealed that high levels of B-MYB correlate with a p53 mutant status and an advanced tumor stage in primary human breast cancer. Taken together, these data suggest that B-MYB/LINC plays an important role in the DNA damage response downstream of p53.
Similar articles
-
A Lin-9 complex is recruited by B-Myb to activate transcription of G2/M genes in undifferentiated embryonal carcinoma cells.Oncogene. 2009 Apr 16;28(15):1737-47. doi: 10.1038/onc.2009.22. Epub 2009 Mar 2. Oncogene. 2009. PMID: 19252525
-
p130/p107/p105Rb-dependent transcriptional repression during DNA-damage-induced cell-cycle exit at G2.J Cell Sci. 2005 May 1;118(Pt 9):1821-32. doi: 10.1242/jcs.02307. Epub 2005 Apr 12. J Cell Sci. 2005. PMID: 15827088
-
Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53.Hepatology. 2011 Apr;53(4):1226-36. doi: 10.1002/hep.24174. Hepatology. 2011. PMID: 21480327
-
Analyzing the G2/M checkpoint.Methods Mol Biol. 2004;280:51-82. doi: 10.1385/1-59259-788-2:051. Methods Mol Biol. 2004. PMID: 15187249 Review.
-
Cell cycle checkpoints and their impact on anticancer therapeutic strategies.J Cell Biochem. 2004 Feb 1;91(2):223-31. doi: 10.1002/jcb.10699. J Cell Biochem. 2004. PMID: 14743382 Review.
Cited by
-
Interplay between HMGA and TP53 in cell cycle control along tumor progression.Cell Mol Life Sci. 2021 Feb;78(3):817-831. doi: 10.1007/s00018-020-03634-4. Epub 2020 Sep 12. Cell Mol Life Sci. 2021. PMID: 32920697 Free PMC article. Review.
-
Cell type- and species-specific host responses to Toxoplasma gondii and its near relatives.Int J Parasitol. 2020 May;50(5):423-431. doi: 10.1016/j.ijpara.2020.05.001. Epub 2020 May 11. Int J Parasitol. 2020. PMID: 32407716 Free PMC article. Review.
-
High-Risk Human Papillomaviral Oncogenes E6 and E7 Target Key Cellular Pathways to Achieve Oncogenesis.Int J Mol Sci. 2018 Jun 8;19(6):1706. doi: 10.3390/ijms19061706. Int J Mol Sci. 2018. PMID: 29890655 Free PMC article. Review.
-
Situational awareness: regulation of the myb transcription factor in differentiation, the cell cycle and oncogenesis.Cancers (Basel). 2014 Oct 2;6(4):2049-71. doi: 10.3390/cancers6042049. Cancers (Basel). 2014. PMID: 25279451 Free PMC article. Review.
-
A chemical screen identifies the chemotherapeutic drug topotecan as a specific inhibitor of the B-MYB/MYCN axis in neuroblastoma.Oncotarget. 2012 May;3(5):535-45. doi: 10.18632/oncotarget.498. Oncotarget. 2012. PMID: 22619121 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous